Our finding that CDCA5 knockdown decreased the phosphorylation level of ERK1/2 and expression of c-jun in CRC cells suggests that activation of the ERK pathway contributes to the oncogenic activities of CDCA5 in CRC. Here, CDCA5 is linked to colorectal carcinoma.